The effect of AZD2171- or sTRAIL/Apo2L-loaded polylactic-co-glycolic acid microspheres on a subcutaneous glioblastoma model
Author:
Publisher
Springer Science and Business Media LLC
Subject
Molecular Biology,Biomedical Engineering
Link
http://link.springer.com/content/pdf/10.1007/s10544-015-9969-2.pdf
Reference58 articles.
1. M.S. Ahluwalia, 2010 Society for Neuro-Oncology Annual Meeting: a report of selected studies. Expert. Rev. Anticancer. Ther. 11(2), 161–163 (2011)
2. A. Arshady, Preparation of biodegradable microspheres and microcapsules: polyactides and related polyester. J. Control. Release 17, 1–21 (1991)
3. B. Auffinger, B. Thaci, P. Nigam, E. Rincon, Y. Cheng, M.S. Lesniak, New therapeutic approaches for malignant glioma: in search of the Rosetta stone. F1000 Med. Rep. 4, 18 (2012)
4. T.T. Batchelor, A.G. Sorensen, E. di Tomaso, W.T. Zhang, D.G. Duda, K.S. Cohen, K.R. Kozak, D.P. Cahill, P.J. Chen, M. Zhu, M. Ancukiewicz, M.M. Mrugala, S. Plotkin, J. Drappatz, D.N. Louis, P. Ivy, D.T. Scadden, T. Benner, J.S. Loeffler, P.Y. Wen, R.K. Jain, AZD2171, a pan-VEGF receptor tyrosine kinase inhibitor, normalizes tumor vasculature and alleviates edema in glioblastoma patients. Cancer Cell 11(1), 83–95 (2007)
5. O. Benny, P. Pakneshan, Novel technologies for antiangiogenic drug delivery in the brain. Cell Adhes. Migr. 3(2), 224–229 (2009)
Cited by 7 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. New Drug Delivery Systems Developed for Brain Targeting;Drugs;2022-05
2. Therapeutic strategies of glioblastoma (GBM): The current advances in the molecular targets and bioactive small molecule compounds;Acta Pharmaceutica Sinica B;2021-12
3. Recent developments in drug delivery strategies for targeting DNA damage response in glioblastoma;Life Sciences;2021-12
4. Pretreating Mesenchymal Stem Cells with Cancer Conditioned‐Media or Proinflammatory Cytokines Changes the Tumor and Immune Targeting by Nanoghosts Derived from these Cells;Advanced Healthcare Materials;2019-04-09
5. Localized targeted antiangiogenic drug delivery for glioblastoma;Journal of Neuro-Oncology;2018-01-11
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3